Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Chyme reinfusion (CR) is a simple technique that reestablishes gastrointestinal continuity. The primary objective was to analyze the pooled evidence of the CR effect on postoperative outcomes following ostomy or fistula repair.
Methods: This meta-analysis was performed according to the current PRISMA guidelines and included all studies that provided postoperative outcome data on CR compared with the control group (no CR) in high-output ostomies and enterocutaneous fistulas. The data from eligible studies were extracted, qualitatively assessed, and included. Odds ratios (ORs) and standardized mean differences (SMDs) with 95% confidence intervals (CIs) were calculated. The risk of bias was assessed using the ROBINS-I criteria.
Results: Five eligible studies with a total of 460 patients were included (CR: n = 219, control: n = 241). CR demonstrated significantly lower rates of overall complications (OR 0.25, 95% CI 0.13-0.46, p < 0.00001), ileus (OR 0.35, 95% CI 0.22-0.53, p < 0.00001), and diarrhea (OR 0.29, 95% CI 0.12-0.69, p = 0.005). As a result, the hospital stay was significantly reduced after CR as compared to the control group (SMD - 0.76, 95% CI - 1.46 to - 0.07, p = 0.03). In addition, the postoperative inflammatory markers CRP (C-reactive protein) (SMD - 0.76, 95% CI - 0.98 to - 0.53, p < 0.0001) and WBC (white blood count) (SMD - 0.67, 95% CI - 1.09 to - 0.25, p = 0.002) were significantly lower after CR.
Conclusions: CR is a safe and easy-to-use method which leads to a significant reduction in inflammatory response and postoperative complications such as ileus or diarrhea and thus significantly shortens the hospital stay. This method should therefore be considered as an additional supportive procedure for patients with high-output ostomies or fistulas. The further legitimacy and justification of CR should now be verified in multi-center randomized studies.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s10620-025-09189-3 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Chyme Reinfusion in Patients with High-Output Enterocutaneous Fistulas and Enterostomies Undergoing Surgical Reconstruction: A Systematic Literature Review and Meta-Analysis.
Dig Dis Sci
July 2025
Department of Surgery (A), Heinrich-Heine-University, Medical Faculty and University Hospital Duesseldorf, Moorenstr. 5, Bldg. 12.46, 40225, Duesseldorf, Germany.
Background: Chyme reinfusion (CR) is a simple technique that reestablishes gastrointestinal continuity. The primary objective was to analyze the pooled evidence of the CR effect on postoperative outcomes following ostomy or fistula repair.
Methods: This meta-analysis was performed according to the current PRISMA guidelines and included all studies that provided postoperative outcome data on CR compared with the control group (no CR) in high-output ostomies and enterocutaneous fistulas.
Advances in Nutritional and Therapeutic Strategies for Type 2 Intestinal Failure: A Narrative Review.
Nutr Rev
June 2025
School of Sport, Exercise and Nutrition, Massey University, Auckland 0632, New Zealand.
This narrative review aims to examine the nutritional consequences of type 2 intestinal failure (T2IF), assess current nutritional therapies, and explore advanced methodologies to address feeding challenges. Type 2 intestinal failure is characterized by severe nutrient malabsorption, micronutrient deficiencies, and disease-related malnutrition, compounded by complications such as microbiota disruption. Effective nutritional management is essential to improve clinical outcomes, yet an evidence gap hinders the establishment of standardized care guidelines.
View Article and Find Full Text PDF[Treatment for Intestinal Failure/Short Bowel Syndrome: Alternatives to Small Bowel Transplantation - What is the International Standard?].
Zentralbl Chir
June 2025
Klinik für Allgemein-, Viszeral-, Kinder- und Transplantationschirurgie, Uniklinik RWTH Aachen, Aachen, Deutschland.
In the treatment of chronic intestinal failure/short bowel syndrome (CIF/SBS), the question of small bowel transplantation may arise. However, the results of small bowel and multivisceral transplantation are not satisfactory, particularly regarding long-term patient and organ survival. According to the expert consensus, the utilisation and combination of alternative methods (nutritional therapy, autologous intestinal reconstruction, chyme reinfusion, pharmacotherapy including GLP-2 analogues) leads to good and viable outcomes.
View Article and Find Full Text PDFChyme reinfusion practices in the neonatal population.
Pediatr Surg Int
November 2024
Department of Surgery, The University of Auckland, Auckland, New Zealand.
Article Synopsis
- Chyme reinfusion therapy (CRT) is a safe technique that enhances nutrition and intestinal health in neonates with stomas, though it’s underused, especially for those with congenital bowel issues or necrotizing enterocolitis.
- A study over ten years at two children's hospitals in New Zealand found that nearly half of the eligible neonates received CRT, leading to improved weight gain, while noting various complications, particularly non-infectious ones.
- Despite the effectiveness of CRT, there's a significant rate of complications (like skin irritation and stoma prolapse), indicating a need for increased awareness and implementation of this therapy in clinical practice for neonates with intestinal failure.